UTAH MEDICAL PRODUCTS INC Cash Flow Statement
UTMD|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
UTAH MEDICAL PRODUCTS INC generated $22M in operating cash flow and $22M in free cash flow in FY2025. Free cash flow margin was 43.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $16.6M | $16.5M | $14.8M | $3.1M | $14.7M | $18.6M | $8.5M | $12.1M | $11.8M | $11.4M | $11.4M | $10.2M | $7.4M | $6.0M | $6.3M |
| Depreciation & Amortization | $623.0K | $612.0K | $636.0K | $655.0K | $700.0K | $765.0K | $660.0K | $610.0K | $619.0K | $637.0K | $611.0K | $653.0K | $707.0K | $563.0K | $555.0K |
| Operating Cash Flow | $22.3M | $21.1M | $21.2M | $20.1M | $17.1M | $16.8M | $16.9M | $14.5M | $13.8M | $15.4M | $12.3M | $13.6M | $11.4M | $7.2M | $7.2M |
| Capital Expenditures | $639.0K | $809.0K | $552.0K | $860.0K | $540.0K | $402.0K | $1.6M | $3.3M | $176.0K | $1.1M | $339.0K | $254.0K | $247.0K | $1.5M | $466.0K |
| Free Cash Flow | $21.6M | $20.3M | $20.7M | $19.3M | $16.5M | $16.4M | $15.3M | $11.2M | $13.6M | $14.3M | $12.0M | $13.3M | $11.1M | $5.6M | $6.8M |
| Share Buybacks | $0 | $2.5M | $0 | $7.0M | $398.0K | $1.2M | $0 | - | - | - | - | - | - | - | - |
| Dividends Paid | $4.3M | $3.2M | $11.5M | $4.1M | $4.1M | $4.0M | $3.0M | $3.9M | $3.8M | $3.8M | $3.7M | $3.6M | $3.4M | $6.0M | $3.3M |
| FCF Margin | 43.1% | 38.9% | 42.1% | 176.8% | 35.2% | 39.1% | 37.0% | 28.6% | 33.9% | 34.6% | 29.6% | 32.0% | 29.4% | 22.4% | 26.1% |